Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ERS International Congress 2021: highlights from the Pulmonary Vascular Diseases Assembly.
Lichtblau M, Piccari L, Ramjug S, Bokan A, Lechartier B, Jutant EM, Barata M, Garcia AR, Howard LS, Adir Y, Delcroix M, Jara-Palomares L, Bertoletti L, Sitbon O, Ulrich S, Vonk Noordegraaf A. Lichtblau M, et al. Among authors: delcroix m. ERJ Open Res. 2022 May 23;8(2):00665-2021. doi: 10.1183/23120541.00665-2021. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35615412 Free PMC article. Review.
EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension.
Sitbon O, Delcroix M, Bergot E, Boonstra AB, Granton J, Langleben D, Subías PE, Galiè N, Pfister T, Lemarié JC, Simonneau G. Sitbon O, et al. Among authors: delcroix m. Am Heart J. 2014 Feb;167(2):210-7. doi: 10.1016/j.ahj.2013.08.007. Epub 2013 Oct 3. Am Heart J. 2014. PMID: 24439982 Free article. Clinical Trial.
Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN.
Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun FO, Mehta S, Perchenet L, Pulido T, Sastry BK, Sitbon O, Souza R, Torbicki A, Rubin LJ. Simonneau G, et al. Among authors: delcroix m. Eur Respir J. 2015 Dec;46(6):1711-20. doi: 10.1183/13993003.00364-2015. Epub 2015 Oct 22. Eur Respir J. 2015. PMID: 26493786 Free PMC article. Clinical Trial.
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.
Delcroix M, Staehler G, Gall H, Grünig E, Held M, Halank M, Klose H, Vonk-Noordegraaf A, Rosenkranz S, Pepke-Zaba J, Opitz CF, Gibbs JSR, Lange TJ, Tsangaris I, Huscher D, Pittrow D, Olsson KM, Hoeper MM. Delcroix M, et al. Eur Respir J. 2018 Nov 8;52(5):1800248. doi: 10.1183/13993003.00248-2018. Print 2018 Nov. Eur Respir J. 2018. PMID: 30337446 Free article.
ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension.
Grünig E, Eichstaedt C, Barberà JA, Benjamin N, Blanco I, Bossone E, Cittadini A, Coghlan G, Corris P, D'Alto M, D'Andrea A, Delcroix M, de Man F, Gaine S, Ghio S, Gibbs S, Gumbiene L, Howard LS, Johnson M, Jurevičienė E, Kiely DG, Kovacs G, MacKenzie A, Marra AM, McCaffrey N, McCaughey P, Naeije R, Olschewski H, Pepke-Zaba J, Reis A, Santos M, Saxer S, Tulloh RM, Ulrich S, Vonk Noordegraaf A, Peacock AJ. Grünig E, et al. Among authors: delcroix m. Eur Respir J. 2019 Feb 28;53(2):1800332. doi: 10.1183/13993003.00332-2018. Print 2019 Feb. Eur Respir J. 2019. PMID: 30578391 Free article.
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.
Newnham M, South K, Bleda M, Auger WR, Barberà JA, Bogaard H, Bunclark K, Cannon JE, Delcroix M, Hadinnapola C, Howard LS, Jenkins D, Mayer E, Ng C, Rhodes CJ, Screaton N, Sheares K, Simpson MA, Southwood M, Su L, Taboada D, Traylor M, Trembath RC, Villar SS, Wilkins MR, Wharton J, Gräf S, Pepke-Zaba J, Laffan M, Lane DA, Morrell NW, Toshner M. Newnham M, et al. Among authors: delcroix m. Eur Respir J. 2019 Mar 28;53(3):1801805. doi: 10.1183/13993003.01805-2018. Print 2019 Mar. Eur Respir J. 2019. PMID: 30655285 Free PMC article.
331 results